Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
On April 7, 2025,
(JNJ) experienced a decline of 1.71%, marking its second consecutive day of losses, with a total decrease of 5.76% over the past two days. The trading volume for the day was 26.92 billion, ranking 34th in the overall market.Johnson & Johnson is set to participate in the BofA Securities 2025 Healthcare Conference on Tuesday, May 13, 2025. This event will provide a platform for the company's management to engage with investors and industry experts, potentially influencing market sentiment and investor confidence in the company's future prospects.
Investor concerns regarding retaliatory tariffs and their potential impact on drug prices for U.S. consumers have led to a decline in shares of pharmaceutical giants, including Johnson & Johnson. This geopolitical risk factor adds to the market's volatility and could continue to affect the stock's performance in the near term.
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios